This narrative review aims to evaluate the role of the microbiome in the pathogenesis, progression, and treatment of ovarian cancer by analyzing published articles. We assessed various aspects of microbiome research in ovarian cancer, including the tumor microenvironment, gut microbiota, and vaginal microbiota, as well as the potential implications for diagnosis, prognosis, and therapeutics. The specialty literature reveals a growing body of evidence supporting the role of the microbiome in ovarian cancer, with potential implications for future clinical practice.
No takes yet. Share an insight, caveat, or question.
Gheorghe et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: